{{Rsnum
|rsid=406193
|Chromosome=20
|position=32811837
|Orientation=plus
|GMAF=0.06795
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 76.9 | 23.1 | 0.0
| HCB | 97.8 | 2.2 | 0.0
| JPT | 99.1 | 0.9 | 0.0
| YRI | 0.0 | 0.0 | 0.0
| ASW | 94.7 | 5.3 | 0.0
| CHB | 97.8 | 2.2 | 0.0
| CHD | 98.1 | 1.9 | 0.0
| GIH | 88.0 | 12.0 | 0.0
| LWK | 96.4 | 3.6 | 0.0
| MEX | 85.5 | 14.5 | 0.0
| MKK | 98.0 | 2.0 | 0.0
| TSI | 76.5 | 23.5 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=19843671
|Title=Genetic variants of methyl metabolizing enzymes and epigenetic regulators: associations with promoter CpG island hypermethylation in colorectal cancer
}}

{{PMID|19124506|OA=1
}} Common genetic variation in candidate genes and susceptibility to subtypes of breast cancer.

{{PMID|20960050|OA=1
}} Dietary methyl donors, methyl metabolizing enzymes, and epigenetic regulators: diet-gene interactions and promoter CpG island hypermethylation in colorectal cancer.

{{PMID Auto
|PMID=22810147
|Title=DNA methyltransferase 3b (DNMT3b), tumor tissue DNA methylation, Gleason score, and prostate cancer mortality: investigating causal relationships.
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}